Asian Phytoceuticals PCL
SET:APCO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.82
8.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches THB.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Asian Phytoceuticals PCL
Total Liabilities & Equity
Asian Phytoceuticals PCL
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Asian Phytoceuticals PCL
SET:APCO
|
Total Liabilities & Equity
฿615m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
D
|
Do Day Dream PCL
SET:DDD
|
Total Liabilities & Equity
฿5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
T
|
Thai Nippon Rubber Industry PCL
SET:TNR
|
Total Liabilities & Equity
฿2.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
I
|
Inter Pharma PCL
SET:IP
|
Total Liabilities & Equity
฿3B
|
CAGR 3-Years
57%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
K
|
Karmarts PCL
SET:KAMART
|
Total Liabilities & Equity
฿4.6B
|
CAGR 3-Years
45%
|
CAGR 5-Years
25%
|
CAGR 10-Years
17%
|
|
|
D
|
DOD Biotech PCL
SET:DOD
|
Total Liabilities & Equity
฿1.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Asian Phytoceuticals PCL
Glance View
Asian Phytoceuticals Public Co., Ltd. engages in the research and development, manufacture, and distribution of health and beauty products from natural extracts. The company is headquartered in Lamphun, Lamphun. The company went IPO on 2011-11-04. The firm specializes in the manufacture of dietary supplements, cosmetics and personal care products developed from natural plant and botanical extracts. The firm offers products across various categories, including anti-wrinkle products, slimming products, and other health products. The Company’s slimming products are sold under Gold Shape brand. The firm's anti-wrinkle and anti-spots products are sold under brands, including Gold Figor, Garcinia and Asian Life. The Company, through its subsidiary, Killer T Cell for Pets Co., Ltd., is engaged in the business of distribution and marketing of pharmaceutical food supplements in the global animal market.
See Also
What is Asian Phytoceuticals PCL's Total Liabilities & Equity?
Total Liabilities & Equity
615m
THB
Based on the financial report for Jun 30, 2024, Asian Phytoceuticals PCL's Total Liabilities & Equity amounts to 615m THB.
What is Asian Phytoceuticals PCL's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
2%
Over the last year, the Total Liabilities & Equity growth was -2%. The average annual Total Liabilities & Equity growth rates for Asian Phytoceuticals PCL have been -2% over the past three years , 1% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
